Literature DB >> 26178252

Deubiquitinating enzymes in cellular signaling and disease regulation.

Pranita Hanpude1, Sushmita Bhattacharya1, Amit Kumar Dey1, Tushar Kanti Maiti1.   

Abstract

Protein post-translational modification by ubiquitin represents a complex signaling system that regulates many cellular events including proteostasis to intercellular communications. Deubiquitinating enzymes (DUBs) that specifically disassemble Ub-chains or regulate ubiquitin homeostasis reside as a central component in ubiquitin signaling. Human genome encodes almost 100 DUBs and majority of them are not well characterized. Considerable progress has been made in the understanding of enzymatic mechanism; however, their cellular substrate specificity and regulation are largely unknown. Involvement of DUBs in disease regulation has been depicted since its discovery and several attempts have been made for evaluating DUBs as a drug target. In this review, we have updated briefly a new insight of DUBs activity, their cellular role, disease regulation, and therapeutic potential.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cysteine proteases; deubiquitinating enzymes; enzyme mechanisms; neurodegenerative disorders; signaling; ubiquitin-proteasome system

Mesh:

Substances:

Year:  2015        PMID: 26178252     DOI: 10.1002/iub.1402

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  43 in total

Review 1.  USP7: Structure, substrate specificity, and inhibition.

Authors:  Alexandra Pozhidaeva; Irina Bezsonova
Journal:  DNA Repair (Amst)       Date:  2019-02-16

2.  UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Authors:  Yanhong Luo; Jianfeng He; Chunlin Yang; Matthew Orange; Xingcong Ren; Nick Blair; Tao Tan; Jin-Ming Yang; Hua Zhu
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

Review 3.  Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.

Authors:  Hirotsugu Oda; Daniel L Kastner
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 4.  Post-translational modifications: How to modulate Rab7 functions.

Authors:  Graziana Modica; Stephane Lefrancois
Journal:  Small GTPases       Date:  2018-01-02

5.  Functional Analysis of Single Nucleotide Polymorphism in ZUFSP Protein and Implication in Pathogenesis.

Authors:  Mary B Ajadi; Opeyemi S Soremekun; Adeniyi T Adewumi; Hezekiel M Kumalo; Mahmoud E S Soliman
Journal:  Protein J       Date:  2021-01-29       Impact factor: 2.371

6.  An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases.

Authors:  Di Chen; Zhen Ning; Huan Chen; Chang Lu; Xiaolong Liu; Tian Xia; Huan Qi; Wen Wang; Ting Ling; Xin Guo; Dinesh Singh Tekcham; Xiumei Liu; Jing Liu; Aman Wang; Qiu Yan; Ji-Wei Liu; Guang Tan; Hai-Long Piao
Journal:  Oncogene       Date:  2019-09-11       Impact factor: 9.867

7.  The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.

Authors:  Chunjie Meng; Jun Zhan; Delin Chen; Genze Shao; Hongquan Zhang; Wei Gu; Jianyuan Luo
Journal:  Oncogene       Date:  2021-02-02       Impact factor: 9.867

Review 8.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

Review 9.  Proteostasis-associated aging: lessons from a Drosophila model.

Authors:  Garbin Yu; Seogang Hyun
Journal:  Genes Genomics       Date:  2020-10-27       Impact factor: 1.839

Review 10.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.